Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Active not recruiting 9Unknown 6Completed 4Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Thoracic 6

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 1

Interventions

Carboplatin 84Cisplatin 79Pemetrexed 72Docetaxel 62Drug Therapy 44Gemcitabine 43Erlotinib Hydrochloride 42Gefitinib 38Radiotherapy 36Paclitaxel 36pembrolizumab 31Bevacizumab 29icotinib 28osimertinib 27anlotinib 26Nivolumab 26camrelizumab 23Vinorelbine 23Radiosurgery 20aumolertinib 18atezolizumab 17sintilimab 16apatinib 16Endostatins 16endostar protein 15durvalumab 14Surgical Procedures, Operative 13Immunotherapy 13Immune Checkpoint Inhibitors 12Blood Specimen Collection 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Non-Small-Cell Lung × lazertinib × Clear all
NCT05338619 2023-09-01

PLATINUM

Korea University Guro Hospital

Phase 2 Unknown
77 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06020989 2023-09-01

CHAMELEON

Yonsei University

Phase 2 Unknown
129 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05716672 2023-02-08

Impact of Lazertinib Dose Modification on Effectiveness and Safety

Pusan National University Hospital

Unknown
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05477615 2022-07-28

Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases

Seoul St. Mary's Hospital

Phase 2 Unknown
28 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05377788 2022-05-19

Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer

Samsung Medical Center

Unknown
900 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05167851 2021-12-22

The Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer

Yonsei University

Phase 2 Unknown
68 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡